- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04026399
Neuroplasticity With Daily Use of a Sensorimotor Priming Vibration System to Improve Hand Function After Stroke
July 28, 2021 updated by: Medical University of South Carolina
More than 4 million stroke survivors in the U.S. suffer from post-stroke sensorimotor hand disability, which is typically permanent and difficult to treat.
Hand disability has a profound negative impact on functional ability and independence.
One way to improve hand function is to use peripheral sensory stimulation.
Sensory stimulation in conjunction with therapy has been shown to improve motor outcomes more than therapy alone.
While promising, most modalities of sensory stimulation interfere with natural hand tasks.
To address these practical limitations, we have developed a new stimulation, imperceptible random-frequency vibration applied to wrist skin via a watch.
In this study, we will determine if use of this vibration increases hand functional recovery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study design is a double-blinded randomized controlled study.
Subjects will wear the device for at least 8 hours/day every day for a month, during which they will come to the laboratory for weekly evaluation.
Follow-up evaluation will occur 3 months after.
The device will deliver vibration (treatment) or no vibration (control).
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Caorlina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic stroke survivor (>= 6 months post stroke)
- Ability to move an object with the paretic hand
- Fingertip sensory deficits
- Ability to put on a watch daily (by oneself or with help)
Exclusion Criteria:
- Currently undergoing other upper extremity rehabilitation therapy
- Upper limb botulinum toxin within 3 months prior to or during enrollment
- Change in neurological disorder medications during the enrollment
- Complete upper limb deafferentation
- Rigidity (Modified Ashworth Scale=5)
- Brainstem stroke
- Comorbidity (peripheral neuropathy, orthopaedic conditions in the hand that limit ranges of motion, premorbid neurologic conditions, compromised skin integrity of the hand/wrist due to long-term use of blood thinners)
- Language barrier or cognitive impairment that precludes following instructions and/or providing consent
If a participant has contraindications for Transcranial Magnetic Stimulation (TMS), the participant will not do TMS.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: stimulation + therapy
The participant receives stimulation and home therapy.
|
wearing a wristband that delivers imperceptible vibratory stimulation.
practice of daily living tasks
|
SHAM_COMPARATOR: no stimulation + therapy
The participant receives no stimulation and receives home therapy.
|
practice of daily living tasks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short-latency Afferent Inhibition
Time Frame: 1 month
|
motor evoked potential suppression by conditioning electrical stimulation
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Action Research Arm Test
Time Frame: 1 month
|
standardized clinical upper extremity function score
|
1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke Impact Scale Hand Subscale
Time Frame: 1 month
|
standardized patient-reported hand function assessment
|
1 month
|
Stoke Impact Scale Hand Subscale
Time Frame: 4 month
|
standardized patient-reported hand function assessment
|
4 month
|
Timing of Reactive Force Generation Per Perturbation
Time Frame: 1 month
|
time of reactive force
|
1 month
|
Timing of Reactive Force Generation Per Perturbation
Time Frame: 4 month
|
time of reactive force
|
4 month
|
Fugl-Meyer Upper Limb Assessment
Time Frame: 1 month
|
standardized clinical upper extremity function score
|
1 month
|
Fugl-Meyer Upper Limb Assessment
Time Frame: 4 month
|
standardized clinical upper extremity function score
|
4 month
|
Grip Force Direction
Time Frame: 1 month
|
angle of the grip force vector from the normal direction
|
1 month
|
Grip Force Direction
Time Frame: 4 month
|
angle of the grip force vector from the normal direction
|
4 month
|
In-home Hand Use Amount
Time Frame: 1 month
|
affected hand use amount as measured by accelerometers
|
1 month
|
In-home Hand Use Amount
Time Frame: 4 month
|
affected hand use amount as measured by accelerometers
|
4 month
|
Reactive Force Magnitude Per Perturbation
Time Frame: 1 month
|
magnitude of reactive grip force
|
1 month
|
Reactive Force Magnitude Per Perturbation
Time Frame: 4 month
|
magnitude of reactive grip force
|
4 month
|
Safety Margin
Time Frame: 1 month
|
additional force used during grip
|
1 month
|
Safety Margin
Time Frame: 4 month
|
additional force used during grip
|
4 month
|
Corticomotor Excitability
Time Frame: 1 month
|
motor evoked potential amplitude
|
1 month
|
Corticomotor Excitability
Time Frame: 4 month
|
motor evoked potential amplitude
|
4 month
|
Spectral Power Perturbation During Grip
Time Frame: 1 month
|
EEG spectral power perturbation during grip
|
1 month
|
Spectral Power Perturbation During Grip
Time Frame: 4 month
|
EEG spectral power perturbation during grip
|
4 month
|
Connectivity
Time Frame: 1 month
|
EEG coherence within the sensorimotor network
|
1 month
|
Connectivity
Time Frame: 4 month
|
EEG coherence within the sensorimotor network
|
4 month
|
Short-latency Afferent Inhibition
Time Frame: 4 month
|
motor evoked potential suppression by conditioning electrical stimulation
|
4 month
|
Box and Block Test
Time Frame: 1 month
|
number of blocks moved in a minute
|
1 month
|
Box and Block Test
Time Frame: 4 month
|
number of blocks moved in a minute
|
4 month
|
Wolf Motor Function Test
Time Frame: 1 month
|
standardized clinical upper extremity function score
|
1 month
|
Wolf Motor Function Test
Time Frame: 4 month
|
standardized clinical upper extremity function score
|
4 month
|
Action Research Arm Test
Time Frame: 4 month
|
standardized clinical upper extremity function score
|
4 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 8, 2019
Primary Completion (ACTUAL)
October 15, 2020
Study Completion (ACTUAL)
October 15, 2020
Study Registration Dates
First Submitted
July 18, 2019
First Submitted That Met QC Criteria
July 18, 2019
First Posted (ACTUAL)
July 19, 2019
Study Record Updates
Last Update Posted (ACTUAL)
August 23, 2021
Last Update Submitted That Met QC Criteria
July 28, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00086207
- P20GM109040 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on peripheral vibration stimulation
-
University of Dublin, Trinity CollegeMotor Neurone Disease Association, UK; Irish Research Council, IE; Thierry Latran... and other collaboratorsRecruitingMultiple Sclerosis | Primary Lateral Sclerosis | Postpoliomyelitis Syndrome | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Motor Neuron Disease Progressive Spinal Muscle AtrophyIreland
-
Umeå UniversityUppsala UniversityCompleted
-
Shepherd Center, Atlanta GAEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedSpinal Cord Injuries | Foot Drop | Spastic GaitUnited States
-
University Hospital, LilleCompletedKnee ArthritisFrance
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingSensorimotor DisorderFrance
-
National Cheng-Kung University HospitalCompletedStroke | Rehabilitation | Hand Grasp
-
Neuromed IRCCSRecruitingParkinson Disease | Movement DisordersItaly
-
Bagcilar Training and Research HospitalCompletedEffects of Vibration | Bone MassTurkey
-
Cristina LirioNot yet recruiting
-
King Saud UniversityCompleted